 MELBOURNE, Australia, March 10, 2021 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT, Nasdaq: OPT, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, today announced that Dr Megan Baldwin, CEO of Opthea, will virtually present and provide a corporate update at the Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021 at 3:50pm ET Wednesday, March 17, 2021 at 6:50am AEDT. 